Immunic reported earnings of -$ 0.99 per IMUX share on Nov 13, 2026, beating analysts' expectations by
| Report Date | Nov 13, 2026 |
|---|---|
| Forecasted EPS | -$ 0.79 |
| Earnings Per Share (Surprise) | -$ 0.99 (-$ 0.20) |
| Last Year's EPS | -$ 1.90 |
| EPS YoY Change |
Out of the last 57 earnings reporting periods, Immunic beat analysts’ expectations 12 times and fell short of expectations 35 time(s). Immunic reported earnings per share of -$ 0.99 in the last report falling to reach an estimated EPS of -$ 0.79 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 13, 2026 | -$ 0.79 | -$ 0.99 | -$ 1.30 | |
| Aug 11, 2026 | -$ 1.16 | -$ 0.80 | -$ 2.00 | |
| May 13, 2026 | -$ 0.71 | -$ 1.08 | -$ 2.50 | |
| Feb 26, 2026 | -$ 0.90 | -$ 1.20 | -$ 2.50 | |
| Nov 13, 2025 | -$ 0.18 | -$ 1.30 | -$ 0.25 | |
| Aug 7, 2025 | -$ 1.58 | -$ 2.00 | -$ 2.40 | |
| May 15, 2025 | -$ 2.50 | -$ 2.50 | -$ 2.10 | |
| Apr 3, 2025 | -$ 0.22 | -$ 2.50 | -$ 2.50 | |
| Mar 31, 2025 | -$ 0.22 | -$ 0.25 | -$ 4.80 | |
| Nov 7, 2024 | -$ 2.20 | -$ 2.40 | -$ 5.10 | |
| Aug 8, 2024 | -$ 0.23 | -$ 2.10 | -$ 5.40 | |
| May 9, 2024 | -$ 0.27 | -$ 2.50 | -$ 5.80 | |
| Feb 22, 2024 | -$ 0.51 | -$ 4.80 | -$ 16.30 | |
| Nov 14, 2023 | -$ 0.55 | -$ 5.10 | -$ 6.90 | |
| Aug 3, 2023 | -$ 0.53 | -$ 5.40 | -$ 7.20 | |
| May 11, 2023 | -$ 0.52 | -$ 5.80 | -$ 7.40 | |
| Feb 23, 2023 | -$ 0.82 | -$ 16.30 | -$ 8.04 | |
| Nov 3, 2022 | -$ 0.67 | -$ 6.90 | -$ 7.60 | |
| Aug 4, 2022 | -$ 0.73 | -$ 7.20 | -$ 8.20 | |
| May 10, 2022 | -$ 0.81 | -$ 7.40 | -$ 16.30 |
Immunic’s stock was trading at $ 7.79 on Nov 12, 2026 a day before the last earnings report was released.
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 13, 2026 | -$ 0.99 | $ 7.79 | ||
| Aug 11, 2026 | -$ 0.80 | $ 14.10 | $ 15.93 | |
| May 13, 2026 | -$ 1.08 | $ 11.90 | $ 12.66 | |
| Feb 26, 2026 | -$ 1.20 | $ 9.10 | $ 10.20 | |
| Nov 13, 2025 | -$ 1.30 | $ 7.60 | $ 7.79 | |
| Aug 7, 2025 | -$ 2.00 | $ 9.79 | $ 8.72 | |
| May 15, 2025 | -$ 2.50 | $ 9.77 | $ 9.61 | |
| Apr 3, 2025 | -$ 2.50 | $ 11.10 | $ 9.95 | |
| Mar 31, 2025 | -$ 0.25 | $ 12.00 | $ 10.70 | |
| Nov 7, 2024 | -$ 2.40 | $ 11.80 | $ 11.80 | |
| Aug 8, 2024 | -$ 2.10 | $ 11.70 | $ 13.30 | |
| May 9, 2024 | -$ 2.50 | $ 12.70 | $ 12.70 | |
| Feb 22, 2024 | -$ 4.80 | $ 12.80 | $ 12.20 | |
| Nov 14, 2023 | -$ 5.10 | $ 9.69 | $ 10.00 | |
| Aug 3, 2023 | -$ 5.40 | $ 21.60 | $ 20.10 | |
| May 11, 2023 | -$ 5.80 | $ 17.90 | $ 17.40 | |
| Feb 23, 2023 | -$ 16.30 | $ 18.90 | $ 18.90 | |
| Nov 3, 2022 | -$ 6.90 | $ 17.10 | $ 15.20 | |
| Aug 4, 2022 | -$ 7.20 | $ 38.90 | $ 53.30 | |
| May 10, 2022 | -$ 7.40 | $ 52.20 | $ 52.40 |
Immunic released its most recent earnings reports in November 2026, August 2026, May 2026, February 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Immunic missed analysts’ expectations during the last earnings period by
